Iridex/Miravant PDT For Macular Degeneration Granted FDA Expedited Review
This article was originally published in The Gray Sheet
Executive Summary
Miravant Medical Technologies and Iridex Corp. are seeking a broader indication for their photodynamic therapy laser than current offerings to treat age-related macular degeneration (AMD)